Can Moderna use its COVID-19 technology to end HIV?
Now, the CDC and FDA have recommended and approved a booster for immunocompromised communities.
The survey also examined how LGBTQ+ people felt during the pandemic and how they have navigated it.
Organizers hope the event will bring in $1 million to local groups working with those living with HIV.
Recent studies out of Johns Hopkins University found the vaccines create similar antibody and immune responses in those who live with HIV and those who don't.
The American Cancer Society estimates there will be almost 250,000 new cases of prostate cancer this year and about 34,000 men will die from the disease.
The antibody cocktail can be given to those who have immunocompromised systems and who have been exposed to COVID-19.